| Cat.No. | Name | Information |
|---|---|---|
| M4808 | TRV130 hydrochloride | TRV130 (Oliceridine) hydrochloride is a novel μ-opioid receptor (MOR) G protein-biased ligand. |
| M1579 | Naloxone | Naloxone is an opioid inverse agonist drug used to counter the effects of opiate overdose. |
| M9615 | DAMGO | DAMGO is an opioid receptor agonist with the ability to affect the locomotive activity in rodents, Kd value is 3.46 nM for native μ-OPR. |
| M41893 | Deltorphin | Deltorphin (Deltorphin A; Dermenkephalin) is a biological active peptide. |
| M41892 | TIPP | TIPP is a potent and selective δ-opioid antagonist with a Ki value of 1.22 nM. |
| M41891 | DSLET | DSLET ([D-Ser2, Leu5, Thr6]-enkephalin) is a highly specific agonist of the δ-receptor. |
| M41890 | ICI 154129 | ICI 154 129 is a delta-opioid receptor antagonist and can be used for seizure research. |
| M41889 | DALDA TFA | DALDA TFA is a potent and highly selective μ-opioid receptor agonist with a Ki of 1.69 nM. |
| M41888 | BAN ORL 24 free base | BAN ORL 24 free base is a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) antagonist. |
| M41887 | DALDA acetate | DALDA acetate is a potent and highly selective μ-opioid receptor agonist with a Ki of 1.69 nM. |
| M41886 | MOR agonist-2 | MOR agonist-2 is a antagonist of D3R and agonist of MOR (Ki: 7.26 nM and 564 nM, respectively). |
| M41885 | GR 89696 free base | GR 89696 free base is a highly selective κ2 opioid receptor agonist with potential to prevent pruritus. |
| M41884 | SR16835 | SR16835 has high affinity for both NOPr and MOPr, with full agonist activity for NOPr and partial agonist activity for MOPr. |
| M40713 | ASP8062 | ASP8062 is an orally active GABAB receptor-positive altered modulator (PAM) that can be used in studies related to opioid-related disorder (OUD). |
| M38964 | Akuammidine | Akuammidine, isolated from the seeds of Picralima nitida, shows a preference for μ-opioid binding sites with Ki values of 0.6, 2.4 and 8.6 μM at μ-, σ- and κ-opioid binding sites, respectively. Akuammidine possesses anti-inflammatory and anti-asthmatic properties. |
| M31391 | TRV734 | TRV734 is an orally bioavailable G-protein-biased ligand for the μ-opioid receptor and an agonist for the μ-opioid receptor. |
| M31390 | TRV250 | TRV250 is a novel delta-like opioid receptor (DOR) small molecule agonist that preferentially selects G-protein signaling with relatively little activation of the β-arrestin2 post-receptor signaling pathway. |
| M31388 | TRV-130 fumarate | TRV-130 fumarate is a biased agonist of the mu-opioid receptor (MOR) and can be used in studies related to acute pain. |
| M30898 | Naldemedine | Naldemedine (S-297995) is an orally active μ-opioid receptor antagonist (PAMORA). Naldemedine shows potent binding affinities (Ki=0.34, 0.43, 0.94 nM, respectively) and antagonist activities (IC50=25.57, 7.09, 16.1 nM, respectively) for recombinant human μ-, δ-, and κ- opioid receptors. Naldemedine can be used in opioid-induced constipation (OIC) research. Naldemedine is predicted to bind to 3CLpro encoded by SARS-CoV2 genome. |
| M30824 | TAN-452 | TAN-452 is an orally active, selective peripherally acting δ-opioid receptor (DOR) antagonist with a Ki of 0.47 nM and a Kb of 0.21 nM. TAN-452 is an antagonist for μ-opioid receptor (MOR; Ki=36.56 nM and Kb=9.43 nM) and κ-opioid receptor (KOR; Ki=5.31 nM and Kb=7.18 nM). TAN-452, a derivative of Naltrindole, demonstrates low brain penetrability and attenuates morphine-induced side effects without affecting pain control. |
| M30799 | Naloxonazine dihydrochloride | Naloxonazine dihydrochloride is a specific μ-opioid receptor antagonist with an IC50 of 5.4 nM. Naloxonazine dihydrochloride also shows anti-leishmanial activity. |
| M30655 | Naloxonazine | Naloxonazine is a potent and selective opiate mu-1 antagonist that can also affect leishmania by regulating host coding function. |
| M30361 | MT-7716 free base | MT-7716 free base (W-212393) is a selective non-peptide nociceptin receptor (NOP) agonist and promising potential treatment drug for alcohol abuse and relapse prevention. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
